Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
Pericarditis I: Introduction01:22

Pericarditis I: Introduction

Pericarditis is defined as the inflammation of the pericardium, the thin, sac-like membrane surrounding the heart. This condition can cause significant chest pain and other symptoms, often necessitating medical intervention. The pericardium has two layers: the inner visceral layer and the outer parietal layer, separated by a small amount of fluid that reduces friction during heartbeats.Types of PericarditisPericarditis can be classified into several types based on the duration and nature of the...
Esophageal Perforation-II: Clinical Manifestations and Management01:28

Esophageal Perforation-II: Clinical Manifestations and Management

Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
Ascites01:19

Ascites

DefinitionAscites is the buildup of fluid inside the peritoneal cavity. It occurs when fluid moves out of the vascular system faster than the peritoneal lymphatics can remove it. This fluid shift is most commonly seen in liver cirrhosis but can also appear in several other systemic disorders.EtiologyCirrhosis remains the leading cause of ascites. Other conditions that can contribute include:Heart failureConstrictive pericarditisAbdominal cancersNephrotic syndromeSevere protein–calorie...
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pilot randomised controlled trial evaluating feasibility, safety and adherence to psyllium husk in peritoneal dialysis: The FIBRE-PD trial.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2026
Same author

Procedure-related PD-peritonitis following gastroscopy and colonoscopy: A 15-year binational data-linkage study from Australia and New Zealand.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2026
Same author

Effect of Hemodiafiltration and Hemodialysis on Postoperative Mortality in Patients With Kidney Failure.

Hemodialysis international. International Symposium on Home Hemodialysis·2026
Same author

Patient and nurse trainer perspectives on a structured PD training programme: A process evaluation of the TEACH-PD feasibility trial.

Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis·2026
Same author

End Point Selection in ADPKD Clinical Trials.

Kidney international reports·2025
Same author

Association of autosomal dominant polycystic kidney disease (ADPKD) with cardiovascular disease and mortality in patients with treated kidney failure.

BMC nephrology·2025

Related Experiment Video

Updated: Jun 14, 2026

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
06:27

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

Encapsulating peritoneal sclerosis: incidence, predictors, and outcomes.

David W Johnson1, Yeoungjee Cho, Brian E R Livingston

  • 1Australia and New Zealand Dialysis and Transplant Registry, Adelaide, South Australia, Australia. david_johnson@health.qld.gov.au

Kidney International
|April 9, 2010
PubMed
Summary

Encapsulating peritoneal sclerosis is a rare complication of peritoneal dialysis. Younger age and longer dialysis duration predict its occurrence, but the risk of death remains low.

More Related Videos

A Mice Model of Chlorhexidine Gluconate-Induced Peritoneal Damage
04:25

A Mice Model of Chlorhexidine Gluconate-Induced Peritoneal Damage

Published on: April 28, 2022

Related Experiment Videos

Last Updated: Jun 14, 2026

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
06:27

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

A Mice Model of Chlorhexidine Gluconate-Induced Peritoneal Damage
04:25

A Mice Model of Chlorhexidine Gluconate-Induced Peritoneal Damage

Published on: April 28, 2022

Area of Science:

  • Nephrology
  • Gastroenterology
  • Clinical Epidemiology

Background:

  • Encapsulating peritoneal sclerosis (EPS) is a serious complication of peritoneal dialysis (PD).
  • EPS presents as adhesive bowel obstruction, impacting PD patient health.
  • Understanding EPS incidence, predictors, and outcomes is crucial for PD management.

Purpose of the Study:

  • To determine the incidence and cumulative incidence of EPS in PD patients.
  • To identify independent predictors of EPS development.
  • To evaluate patient survival outcomes following EPS diagnosis.

Main Methods:

  • Multivariate logistic regression analysis of incident PD patients in Australia and New Zealand.
  • Matched case-control analysis comparing survival between EPS patients and controls.
  • Data collected over a 13-year period from 7618 patients.

Main Results:

  • The incidence of EPS was 1.8 per 1000 patient-years, with cumulative incidences of 0.3% (3 years), 0.8% (5 years), and 3.9% (8 years).
  • Younger age and longer duration of PD independently predicted EPS; peritonitis rate was not a predictor.
  • Median survival post-diagnosis was 4 years, not significantly different from matched controls. Mortality directly attributed to EPS was low.

Conclusions:

  • Encapsulating peritoneal sclerosis is a rare complication of PD.
  • Younger age and longer PD duration are key predictors.
  • The prognosis for EPS patients is relatively favorable, with low attributable mortality compared to other risks in PD patients.